AbCellera to Present at Upcoming Investor Conferences in May and June 2026
Friday, May 8, 2026 1 min read
Key Takeaway: AbCellera Biologics Inc. announced its participation in upcoming investor conferences scheduled for May and June 2026. The company will provide live audio webcasts of its presentations, which will also be available for replay afterward. AbCellera specializes in developing first-in-class antibody-based therapies across various medical fields.
Market Sentiment Analysis
POSITIVE FACTORS
AbCellera is actively engaging with investors through presentations.
The company is focused on innovative antibody-based medicines.
Webcasts provide accessible information for stakeholders.
Full Press Release Details
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera(Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:
A live audio webcast of each presentation may be accessed through a link that will be posted onAbCellera’s Investor Relations websitecloser to date. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera(Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visitwww.abcellera.com.